Ayyildiz A, Koc H, Turkekul K, Erdogan S. Co-administration of apigenin with doxorubicin enhances anti-migration and antiproliferative effects via PI3K/PTEN/AKT pathway in prostate cancer cells. Exp. oncol. [Internet]. 2023 May 26 [cited 2025 Dec. 16];43(2):125-34. Available from: https://exp-oncology.com.ua/index.php/Exp/article/view/2021-2-5